United States - English - NLM (National Library of Medicine)

nnodum pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), intrinsic factor (unii: 70bt6oqt2q) (intrinsic factor - unii:70bt6oqt2q), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - ferrous cation 66 mg - for the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence. hemochromatosis and hemosiderosis are contraindications to iron therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

carotino (australia) pty ltd - biotin, quantity: 1.6 microgram/ml; calcium pantothenate, quantity: 440 microgram/ml; choline bitartrate, quantity: 30.64 mg/ml; cyanocobalamin, quantity: 0.2 microgram/ml; ferrous fumarate, quantity: 3.05 mg/ml (equivalent: iron, qty 1 mg/ml); folic acid, quantity: 20 microgram/ml; nicotinamide, quantity: 1 mg/ml; pyridoxine hydrochloride, quantity: 150 microgram/ml (equivalent: pyridoxine, qty 123.5 microgram/ml); riboflavin, quantity: 120 microgram/ml; thiamine hydrochloride, quantity: 140 microgram/ml; zinc sulfate monohydrate, quantity: 1.1 mg/ml (equivalent: zinc, qty 400.7 microgram/ml); colecalciferol, quantity: 1.6 microgram/ml; retinol palmitate, quantity: 36.85 microgram/ml - oral liquid - excipient ingredients: glycerol; carmoisine; potassium sorbate; purified water; sodium benzoate; sucralose; xanthan gum; maize starch; acacia; silicon dioxide; dl-alpha-tocopherol; sucrose; medium chain triglycerides; potable water; gelatin; butylated hydroxytoluene; aluminium starch octenylsuccinate; aluminium sodium silicate; flavour - maintain/support energy levels ; maintain/support nail health/strength/thickness ; aid/assist healthy red blood cell production ; aid/assist/helps oxygen transport to body tissues ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; maintain/support cognitive function/mental function ; maintain/support brain function ; maintain/support skin health

United States - English - NLM (National Library of Medicine)

amella pharma, llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1js2w), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), zinc citrate (unii: k72i3dex9b) (zinc cation - unii:13s1s8sf37) - feonyx should not be used by patients with a known hypersensitivity to any of the listed ingredients. all iron compounds are contraindicated in patients with hemochromatosis, hemosiderosis, or hemolytic anemias. precautions: general: take 2 hours after meals. do not exceed recommended dose. discontinue use if symptoms of intolerance appear. the type of anemia and the underlying cause or causes should be determined before starting therapy with feonyx tablets. ensure hgb, hct, reticulocyte count are determined before starting therapy and periodically thereafter during prolonged treatment. periodically review therapy to determine if it needs to be continued without change or if a dose change is indicated. since the anemia may be a result of a systemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible. folic acid: folic acid alone is an improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin b12 is deficient. f

Philippines - English - FDA (Food And Drug Administration)

unilab, inc.; importer: n/a; distributor: n/a - thiamine mononitrate (vitamin b1) , pyridoxine hydrochloride (vitamin b6) , folic acid (vitamin b9) , cyanocobalamin (vitamin b12) , iron - film-coated tablet - each film-coated tablet contains: iron, elemental (as ferrous fumarate 300 mg) 98.6 mg; folic acid 500 mcg; thiamine mononitrate (vitamin b1) 5 mg; pyridoxine hydrochloride (vitamin b6) 5 mg; cyanocobalamin (vitamin b12) 15 mcg

Uganda - English - National Drug Authority

laborate pharmaceuticals india limited - ferrous sulphate + folic acid - oral solid ordinary film-coated tablets - 60 mg + 0.6 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

thornton & ross ltd - ferrous fumarate; folic acid - oral capsule - 305mg ; 350microgram

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

mega lifesciences sdn. bhd. - folic acid; ferrous fumarate; cyanocobalamin -

Australia - English - Department of Health (Therapeutic Goods Administration)

vitex pharmaceuticals pty ltd - ferrous fumarate,folic acid -

Ireland - English - HPRA (Health Products Regulatory Authority)

galen limited - ferrous fumarate sodium ascorbate nicotinamide thiamine mononitrate riboflavin pyridoxine hydrochloride folic acid - capsule - %v/v

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dynapharm (m) sdn bhd - ferrous fumarate -